195 related articles for article (PubMed ID: 32483521)
1. Supramolecular Polysaccharide Nanotheranostics that Inhibit Cancer Cells Growth and Monitor Targeted Therapy Response.
Deshpande N; Ramesh A; Nandi D; Nguyen A; Brouillard A; Kulkarni A
Nanotheranostics; 2020; 4(3):156-172. PubMed ID: 32483521
[TBL] [Abstract][Full Text] [Related]
2. Trojan-Horse Diameter-Reducible Nanotheranostics for Macroscopic/Microscopic Imaging-Monitored Chemo-Antiangiogenic Therapy.
Fan Z; Shi D; Zuo W; Feng J; Ge D; Su G; Yang L; Hou Z
ACS Appl Mater Interfaces; 2022 Feb; 14(4):5033-5052. PubMed ID: 35045703
[TBL] [Abstract][Full Text] [Related]
3. Copper sulfide nanoparticle-based localized drug delivery system as an effective cancer synergistic treatment and theranostic platform.
Hou L; Shan X; Hao L; Feng Q; Zhang Z
Acta Biomater; 2017 May; 54():307-320. PubMed ID: 28274767
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapeutic drug-photothermal agent co-self-assembling nanoparticles for near-infrared fluorescence and photoacoustic dual-modal imaging-guided chemo-photothermal synergistic therapy.
Li Y; Liu G; Ma J; Lin J; Lin H; Su G; Chen D; Ye S; Chen X; Zhu X; Hou Z
J Control Release; 2017 Jul; 258():95-107. PubMed ID: 28501673
[TBL] [Abstract][Full Text] [Related]
5. Stimuli-Responsive Nanotheranostics for Real-Time Monitoring Drug Release by Photoacoustic Imaging.
Yang Z; Song J; Tang W; Fan W; Dai Y; Shen Z; Lin L; Cheng S; Liu Y; Niu G; Rong P; Wang W; Chen X
Theranostics; 2019; 9(2):526-536. PubMed ID: 30809290
[TBL] [Abstract][Full Text] [Related]
6. Using Peptide Aptamer Targeted Polymers as a Model Nanomedicine for Investigating Drug Distribution in Cancer Nanotheranostics.
Zhao Y; Houston ZH; Simpson JD; Chen L; Fletcher NL; Fuchs AV; Blakey I; Thurecht KJ
Mol Pharm; 2017 Oct; 14(10):3539-3549. PubMed ID: 28880092
[TBL] [Abstract][Full Text] [Related]
7. Tumor-targeted nanomedicines for cancer theranostics.
Arranja AG; Pathak V; Lammers T; Shi Y
Pharmacol Res; 2017 Jan; 115():87-95. PubMed ID: 27865762
[TBL] [Abstract][Full Text] [Related]
8. Theranostic pH-sensitive nanoparticles for highly efficient targeted delivery of doxorubicin for breast tumor treatment.
Pan C; Liu Y; Zhou M; Wang W; Shi M; Xing M; Liao W
Int J Nanomedicine; 2018; 13():1119-1137. PubMed ID: 29520140
[TBL] [Abstract][Full Text] [Related]
9. Facile Supramolecular Approach to Nucleic-Acid-Driven Activatable Nanotheranostics That Overcome Drawbacks of Photodynamic Therapy.
Li X; Yu S; Lee D; Kim G; Lee B; Cho Y; Zheng BY; Ke MR; Huang JD; Nam KT; Chen X; Yoon J
ACS Nano; 2018 Jan; 12(1):681-688. PubMed ID: 29232105
[TBL] [Abstract][Full Text] [Related]
10. Cu-In-S/ZnS@carboxymethylcellulose supramolecular structures: Fluorescent nanoarchitectures for targeted-theranostics of cancer cells.
Mansur AAP; Amaral-Júnior JC; Carvalho SM; Carvalho IC; Mansur HS
Carbohydr Polym; 2020 Nov; 247():116703. PubMed ID: 32829831
[TBL] [Abstract][Full Text] [Related]
11. In vitro/vivo evaluation of novel mitochondrial targeting charge-reversal polysaccharide-based antitumor nanoparticle.
Fang L; Lin H; Wu Z; Wang Z; Fan X; Cheng Z; Hou X; Chen D
Carbohydr Polym; 2020 Apr; 234():115930. PubMed ID: 32070547
[TBL] [Abstract][Full Text] [Related]
12. pH-Sensitive nanotheranostics for dual-modality imaging guided nanoenzyme catalysis therapy and phototherapy.
Wang S; Mao J; Liu H; Huang S; Cai J; Gui W; Wu J; Xu J; Shen J; Wang Z
J Mater Chem B; 2020 Jun; 8(22):4859-4869. PubMed ID: 32100793
[TBL] [Abstract][Full Text] [Related]
13. Hybrid silica-coated Gd-Zn-Cu-In-S/ZnS bimodal quantum dots as an epithelial cell adhesion molecule targeted drug delivery and imaging system.
Akbarzadeh M; Babaei M; Abnous K; Taghdisi SM; Peivandi MT; Ramezani M; Alibolandi M
Int J Pharm; 2019 Oct; 570():118645. PubMed ID: 31465835
[TBL] [Abstract][Full Text] [Related]
14. A robust strategy for preparation of sequential stimuli-responsive block copolymer prodrugs via thiolactone chemistry to overcome multiple anticancer drug delivery barriers.
Ke W; Yin W; Zha Z; Mukerabigwi JF; Chen W; Wang Y; He C; Ge Z
Biomaterials; 2018 Feb; 154():261-274. PubMed ID: 29149720
[TBL] [Abstract][Full Text] [Related]
15. Supramolecular cancer nanotheranostics.
Zhou J; Rao L; Yu G; Cook TR; Chen X; Huang F
Chem Soc Rev; 2021 Feb; 50(4):2839-2891. PubMed ID: 33524093
[TBL] [Abstract][Full Text] [Related]
16. HP-β-CD Functionalized Fe
Song S; Chong Y; Fu H; Ning X; Shen H; Zhang Z
ACS Appl Mater Interfaces; 2018 Oct; 10(40):33867-33878. PubMed ID: 30215249
[TBL] [Abstract][Full Text] [Related]
17. A pH-sensitive nanotherapeutic system based on a marine sulfated polysaccharide for the treatment of metastatic breast cancer through combining chemotherapy and COX-2 inhibition.
Zhang T; Liu H; Li Y; Li C; Wan G; Chen B; Li C; Wang Y
Acta Biomater; 2019 Nov; 99():412-425. PubMed ID: 31494294
[TBL] [Abstract][Full Text] [Related]
18. Supramolecular Nanotheranostics.
Chen X; Zheng G; Cheng J; Yang YY
Theranostics; 2019; 9(11):3014-3016. PubMed ID: 31244939
[TBL] [Abstract][Full Text] [Related]
19. A supramolecular nanoparticle system based on β-cyclodextrin-conjugated poly-l-lysine and hyaluronic acid for co-delivery of gene and chemotherapy agent targeting hepatocellular carcinoma.
Xiong Q; Cui M; Bai Y; Liu Y; Liu D; Song T
Colloids Surf B Biointerfaces; 2017 Jul; 155():93-103. PubMed ID: 28411478
[TBL] [Abstract][Full Text] [Related]
20. Novel theranostic zinc phthalocyanine-phospholipid complex self-assembled nanoparticles for imaging-guided targeted photodynamic treatment with controllable ROS production and shape-assisted enhanced cellular uptake.
Ma J; Li Y; Liu G; Li A; Chen Y; Zhou X; Chen D; Hou Z; Zhu X
Colloids Surf B Biointerfaces; 2018 Feb; 162():76-89. PubMed ID: 29154189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
